Recent News
Read ArticleAnnals of Internal Medicine has published a retrospective study of long-term routine laboratory toxicity monitoring (lt-RLTM) in patients receiving disease-modifying antirheumatic drug (DMARD) therapy showing that most very abnormal laboratory finding occur early in therapy (first 6 months) or are anticipated or only after dose escalation.
ACR Urges Alaska and Montana to Strengthen Rheumatology Care
ACR
The American College of Rheumatology (ACR) is calling on Alaska and Montana to seize the opportunity to address critical gaps in rheumatology care by accessing funding from the Rural Health Transformation Program (RHTP), provided by the One Big Beautiful Bill Act (H.R. 1), signed into law on July 4, 2025.
Read Article
Prenatal acetaminophen linked to increased autism and ADHD
Researchers at the Icahn School of Medicine at Mount Sinai have found that prenatal exposure to acetaminophen may increase the risk of neurodevelopmental disorders, including autism spectrum disorder and ADHD, in https://t.co/Zpo9dymPPf
Dr. John Cush @RheumNow ( View Tweet)
Antibiotics are not linked to Autoimmune disease in kids
The global incidence of autoimmune diseases among children has increased over the past few decades. A study published August 21st in the open-access journal PLOS Medicine by Ju-Young Shin at Sungkyunkwan University, https://t.co/46Q0GFZQiw
Dr. John Cush @RheumNow ( View Tweet)
š NEW FROM EULAR: Real-world effectiveness of switching to a JAKi after first-line TNFi in PsA
See how second-line treatment choices impacted TJC and SJC in patients from the Adelphi database. Poster sponsored by AbbVie Medical Affairs + Health Impact.
https://t.co/U6EptuGZi0 https://t.co/Yxa0Dc3yde
Dr. John Cush @RheumNow ( View Tweet)
Ambient Dictation Works and Reduces Burnout
MedPage Today
Passive documentation of clinic visits using artificial intelligence (AI)-drafted notes was linked to reduced burnout and improved well-being, a survey study from two academic medical centers suggested.
Read Article
Osteoporosis in Older Men
JAMA has publish an invited commentary on Screening for Osteoporosis (OP) in Older Men. They point out that a simple screening strategy for older men based on previous fracture history and bone density screening at age 70 or 75 years is a reasonable means of screening for OP in older men.
Read Article
"Never doubt that a small group of thoughtful, committed citizens can change the world; indeed, it's the only thing that ever has." - Margaret Mead
You are thoughtful, and committed. You will change this world! https://t.co/OFGN223bPa
Dr. John Cush @RheumNow ( View Tweet)
RHEUM Survey: How important is "Seropositivity" in RA?
Dr. John Cush @RheumNow ( View Tweet)
While the live-attenuated vaccine, Ixchiq, was pulled for safety concerns, there is another chikungunya vax still on the marked - a virus-like particle vaccine, Vimkunya. Travelers or the elderly at higher risk of chikungunya exposure should consider getting vaccinated
Dr. John Cush @RheumNow ( View Tweet)
š©āļøš§āļø RheumIQ is here.
Each week, challenge yourself with 5 quick questions on the latest in rheumatology.
ā
Fast
ā
Evidence-based
ā
Competitive
ā”ļø Test your RheumIQ today: https://t.co/OjhbnTjFyZ https://t.co/JrPfPn3N8n
Links:
Dr. John Cush @RheumNow ( View Tweet)
MUC5 mutations not in SSc-ILD. Study of 2363 SSc-ILD, 3526 SSc w/o ILD & 15076 controls. They found no assoc w/ MUC5B promoter variant & SSc-ILD. (Suggesting ILD pathogenic mechanisms differ between RA and SSc) https://t.co/bBq52X0Mwq https://t.co/QdUzra1fnj
Dr. John Cush @RheumNow ( View Tweet)
September is Rheumatic Disease Awareness Month! ARP president Adam Goode, Encourages Physical Activity During September - exercise, move, & get strong!! https://t.co/HhdnJdvBjR https://t.co/BuqTAMJaqN
Dr. John Cush @RheumNow ( View Tweet)
Wait! FDA approved the Chikungunya Virus Vaccine 2 yrs ago, but just pulled the vaccine, Ixchiq, citing serious safety concerns (specifically CBER reports of >20 serious adverse events, including 21 hospitalizations, 3 deaths, w/ 1 fatality directly linked to vaccine-derived https://t.co/k5wBtsGVIs
Dr. John Cush @RheumNow ( View Tweet)
Methotrexate intolerance in rheumatoid arthritis
Methotrexate (MTX) is the most commonly used DMARD in rheumatoid arthritis (RA); however, there is significant intolerance to this drug among adult RA patients - especially at doses above 15 mg per week.
Read Article
New #therapy in #SLE
#lupus https://t.co/TPeKxfw9hq
Dr hanady manasfi @hanadymanasfi ( View Tweet)
What Is Lyme Disease?
JAMA Patient education handout. Lyme disease is the most common tick-borne infection in the US. A bite from infected Ixodes scapularis ticks can transmit the bacterium Borrelia burgdorferi, which causes Lyme disease. https://t.co/a8eMdAy0bi https://t.co/Jrj4Eiuy24
Dr. John Cush @RheumNow ( View Tweet)
Recombinant zoster vaccine effective in #SLE without flare. Retrospective Medicare & commercial claims data on pts given 2 RZV doses, matched 1:4 to unVAX. 3592 pts F?u ~1.5 yrs. Vax effectiveness 70% in Medicare; 54% commercial. SLE flare rates HR 0.91& 0.94. https://t.co/bcEwtzFDvy
Dr. John Cush @RheumNow ( View Tweet)
Metanalysis shows patients w/ psoriasis have signif. higher risk (2-2.5 fold) of metabolic syndrome compared to the general population, RA or spondylitis patients. Comparing PsO to PsA there is no difference (PsA also has a high riskof MetS). https://t.co/gO3IomfP53 https://t.co/Ov2UHV2mN6
Dr. John Cush @RheumNow ( View Tweet)
Celltrions tocilizumab biosimilar, tocilizumab-anoh (Avtozma, CT-P47), had similar efficacy when switching from reference tocilizumab (Actemra; Genentech) in a study of 444 RA patients x 52 wks. https://t.co/7aAyuUkZJ9 https://t.co/kJUrRkhstb
Dr. John Cush @RheumNow ( View Tweet)
Primary CNS angiitis - an uncommon vasculitis affecting brain, spinal cord, or leptomeninges, typically B/L, but here are 48 pts w/ unilateral PACNS. Dx is made by imaging, wall imaging (VWI), perfusion, spectroscopy. Histology shows small-to med vessel lymphocytic vasculitis https://t.co/ji0oaGfdJf
Dr. John Cush @RheumNow ( View Tweet)
From the blog
Podcasts
Derm on RheumNow (Aug 2025)
Sjogrens Graduates (8.22.2025)-
Teaching You How to Thinkā¦ (8.15.2025)
-
Repurposing & Pipeline (8.8.2025)
Therapeutic Updates
Structural damage progression in active PsA
Sponsored by Johnson & Johnson
Watch Dr. Philip Mease discuss the impact of structural damage on active PsA and follow along as he reviews clinical trial data
Read Post
Navigating the Path to SLE Remission
Sponsored by AstraZeneca Medical Affairs
Watch rheumatologists Dr Anca Askanase and Dr Cristina Arriens discuss their clinical perspectives on how to target and achieve DORIS remission in clinical practice.
Read Post
Poster Hall
Sponsored by AbbVie Medical Affairs + Health Impact
